Legal Opinion

Amgen Inc. v. Hoechst Marion Roussel, Inc.

District Court, D. Massachusetts

Decided October 2, 2008No. Civil Action 97-10814-WGYPublished

1Opinion of the Court

MEMORANDUM AND ORDER

YOUNG, District Judge.

Amgen brought this action seeking a declaratory judgment of infringement of several patents related to recombinant er-ythropoietin (“EPO”), which mimics a naturally occurring hormone that stimulates production of red blood cells. Amgen, Inc. v. Hoechst Marion Roussel, Inc., 339 F.Supp.2d 202, 213 (D.Mass.2004) [hereinafter “Amgen III ”]. Over the past decade, the Court has taken evidence in two bench trials, and this Court’s opinions have twice been appealed to the Federal Circuit. See Amgen, Inc. v. Hoechst Marion Roussel, Inc., 457 F.3d 1293,…

2Cases cited10 opinions

MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
Amgen Inc., Plaintiff-Cross v. Hoechst Marion Roussel, Inc. (Now Known as Aventis Pharmaceuticals, Inc.) and Transkaryotic Therapies, Inc.Court of Appeals for the Federal Circuit · 2003
Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
In Re Omeprazole Patent Litigation. Astra Aktiebolag, Aktiebolaget Hassle, Astra Merck Enterprises Inc., Astra Merck Inc., Kbi-E, Inc., Kbi, Inc., and Astrazeneca Lp, Plaintiffs-Cross v. Andrx Pharmaceuticals, Inc., and Genpharm, Inc., Kremers Urban Development Co., and Schwarz Pharma, Inc.Court of Appeals for the Federal Circuit · 2007
Amgen v. Hoechst Marion Roussel (Now Known as Aventis Pharmaceuticals)Court of Appeals for the Federal Circuit · 2006

5 more not listed; retrieve them via the Exa API.